119 related articles for article (PubMed ID: 38407192)
21. Serological screening of immunoglobulin M and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection.
Torii Y; Yoshida S; Yanase Y; Mitsui T; Horiba K; Okumura T; Takeuchi S; Suzuki T; Kawada JI; Kotani T; Yamashita M; Ito Y
BMC Pregnancy Childbirth; 2019 Jun; 19(1):205. PubMed ID: 31221131
[TBL] [Abstract][Full Text] [Related]
22. Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay.
Smith TF; Shelley CD
J Virol Methods; 1988 Sep; 21(1-4):87-96. PubMed ID: 2846623
[TBL] [Abstract][Full Text] [Related]
23. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
[TBL] [Abstract][Full Text] [Related]
24. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development.
Fowler K; Mucha J; Neumann M; Lewandowski W; Kaczanowska M; Grys M; Schmidt E; Natenshon A; Talarico C; Buck PO; Diaz-Decaro J
BMC Public Health; 2022 Sep; 22(1):1659. PubMed ID: 36050659
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay.
Nielsen SL; Sørensen I; Andersen HK
J Clin Microbiol; 1988 Apr; 26(4):654-61. PubMed ID: 2835388
[TBL] [Abstract][Full Text] [Related]
26. Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
Salwender H; Bertsch U; Weisel K; Duerig J; Kunz C; Benner A; Blau IW; Raab MS; Hillengass J; Hose D; Huhn S; Hundemer M; Andrulis M; Jauch A; Seidel-Glaetzer A; Lindemann HW; Hensel M; Fronhoffs S; Martens U; Hansen T; Wattad M; Graeven U; Munder M; Fenk R; Haenel M; Scheid C; Goldschmidt H
BMC Cancer; 2019 May; 19(1):504. PubMed ID: 31138244
[TBL] [Abstract][Full Text] [Related]
27. Cytomegalovirus (CMV) excretion as a factor in the severity of CMV disease in kidney and simultaneous kidney and pancreas transplantation.
Pouteil-Noble C; Ecochard R; Bosshard S; Lacavalerie B; Donia A; Landrivon G; Tardy JC; Dubernard JM; Aymard M; Touraine JL
Transpl Int; 1992; 5 Suppl 1():S26-9. PubMed ID: 14621724
[TBL] [Abstract][Full Text] [Related]
28. Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation.
Yamazaki R; Tanaka Y; Nakasone H; Sato M; Terasako-Saito K; Sakamoto K; Akahoshi Y; Nakano H; Ugai T; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Ashizawa M; Kimura SI; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Transpl Infect Dis; 2014 Dec; 16(6):904-13. PubMed ID: 25367140
[TBL] [Abstract][Full Text] [Related]
29. Seroepidemiology Study of Cytomegalovirus and Rubella among Pregnant Women at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Yeshwondm M; Balkachew N; Delayehu B; Mekonen G
Ethiop J Health Sci; 2016 Sep; 26(5):427-438. PubMed ID: 28446848
[TBL] [Abstract][Full Text] [Related]
30. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.
Palafox Sánchez CA; Satoh M; Chan EK; Carcamo WC; Muñoz Valle JF; Orozco Barocio G; Oregon Romero E; Navarro Hernández RE; Salazar Páramo M; Cabral Castañeda A; Vázquez Del Mercado M
Arthritis Res Ther; 2009; 11(1):R27. PubMed ID: 19232124
[TBL] [Abstract][Full Text] [Related]
31. [Cytomegalovirus IgM amd IgG antibodies in the sera of patients with acute and chronic upper respiratory infections].
Cengiz AT; Ataoğlu H; Kiyan M; Kiliç H
Mikrobiyol Bul; 1990 Oct; 24(4):307-13. PubMed ID: 1962842
[TBL] [Abstract][Full Text] [Related]
32. Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.
Adane T; Getawa S
J Int Med Res; 2021 Aug; 49(8):3000605211034656. PubMed ID: 34382466
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of Cytomegalovirus Infection Among HIV-Infected and HIV-Uninfected Pregnant Women Attending Antenatal Clinic in Harare, Zimbabwe.
Mhandire D; Duri K; Kaba M; Mhandire K; Musarurwa C; Chimusa E; Munjoma P; Mazengera L; Stray-Pedersen B; Dandara C
Viral Immunol; 2019 Sep; 32(7):289-295. PubMed ID: 31347990
[TBL] [Abstract][Full Text] [Related]
34. Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study.
Périllaud-Dubois C; Bouthry E; Jadoui A; Leng AL; Roque-Afonso AM; Vauloup-Fellous C
J Clin Virol; 2020 Nov; 132():104641. PubMed ID: 32947202
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States.
Wang C; Dollard SC; Amin MM; Bialek SR
PLoS One; 2016; 11(3):e0151996. PubMed ID: 26990759
[TBL] [Abstract][Full Text] [Related]
36. Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy.
Fourgeaud J; Nguyen CÂ; Guilleminot T; Ville Y; Leruez-Ville M
J Clin Virol; 2023 Dec; 169():105614. PubMed ID: 37982548
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
38. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
40. Analysis of chemokines and soluble adhesion molecules in cytomegalovirus-positive renal transplant recipients.
Obeid OE; Alzahrani AJ
J Infect Dev Ctries; 2010 Mar; 4(2):110-3. PubMed ID: 20212343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
